Rosuvastatin News and Research

RSS
Recaticimab injection every 1-3 months may safely lower bad cholesterol

Recaticimab injection every 1-3 months may safely lower bad cholesterol

Study compares two widely used statins for treating patients with coronary artery disease

Study compares two widely used statins for treating patients with coronary artery disease

Investigating treat-to-target low-density lipoprotein-cholesterol versus high-intensity statins for coronary artery disease

Investigating treat-to-target low-density lipoprotein-cholesterol versus high-intensity statins for coronary artery disease

Dietary supplements taken for 'heart health' unlikely to offer meaningful impact on cholesterol levels

Dietary supplements taken for 'heart health' unlikely to offer meaningful impact on cholesterol levels

Rosuvastatin vastly superior to six common heart health supplements

Rosuvastatin vastly superior to six common heart health supplements

Exploring the muscle symptoms associated with statin therapy

Exploring the muscle symptoms associated with statin therapy

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

What is the optimal LDL cholesterol level for patients with cardiovascular diseases?

Study predicts that different statins exhibit divergent effects on host response to SARS-CoV-2 infection

Study predicts that different statins exhibit divergent effects on host response to SARS-CoV-2 infection

Addition of alirocumab to high-intensity statin treatment reduces key measures of plaque vulnerability

Addition of alirocumab to high-intensity statin treatment reduces key measures of plaque vulnerability

Study: Benefit-to-harm balance of statins for primary prevention of heart disease is favorable

Study: Benefit-to-harm balance of statins for primary prevention of heart disease is favorable

Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection

Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection

Statin use alone or with metformin may increase survival in high-risk prostate cancer patients

Statin use alone or with metformin may increase survival in high-risk prostate cancer patients

Potency and dosage of statins linked to diagnosis of osteoporosis

Potency and dosage of statins linked to diagnosis of osteoporosis

Higher dosage of statins can increase risk of osteoporosis, shows study

Higher dosage of statins can increase risk of osteoporosis, shows study

Statins are recommended far too often, study shows

Statins are recommended far too often, study shows

Study examines timing of musculoskeletal adverse events that develop during statin therapy

Study examines timing of musculoskeletal adverse events that develop during statin therapy

PCSK9 inhibitor reduces cardiovascular events in ACS patients with high cholesterol

PCSK9 inhibitor reduces cardiovascular events in ACS patients with high cholesterol

Blood pressure and cholesterol lowering drugs do not negatively affect erectile function, study says

Blood pressure and cholesterol lowering drugs do not negatively affect erectile function, study says

Common anti-cholesterol drugs show promise for reducing Alzheimer's disease risk

Common anti-cholesterol drugs show promise for reducing Alzheimer's disease risk

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

High-intensity statin treatments increase survival rates in patients with cardiovascular disease